Correlation Between Tonix Pharmaceuticals and Moleculin Biotech
Can any of the company-specific risk be diversified away by investing in both Tonix Pharmaceuticals and Moleculin Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tonix Pharmaceuticals and Moleculin Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tonix Pharmaceuticals Holding and Moleculin Biotech, you can compare the effects of market volatilities on Tonix Pharmaceuticals and Moleculin Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tonix Pharmaceuticals with a short position of Moleculin Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tonix Pharmaceuticals and Moleculin Biotech.
Diversification Opportunities for Tonix Pharmaceuticals and Moleculin Biotech
-0.75 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Tonix and Moleculin is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding Tonix Pharmaceuticals Holding and Moleculin Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Moleculin Biotech and Tonix Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tonix Pharmaceuticals Holding are associated (or correlated) with Moleculin Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Moleculin Biotech has no effect on the direction of Tonix Pharmaceuticals i.e., Tonix Pharmaceuticals and Moleculin Biotech go up and down completely randomly.
Pair Corralation between Tonix Pharmaceuticals and Moleculin Biotech
Given the investment horizon of 90 days Tonix Pharmaceuticals Holding is expected to generate 2.33 times more return on investment than Moleculin Biotech. However, Tonix Pharmaceuticals is 2.33 times more volatile than Moleculin Biotech. It trades about 0.2 of its potential returns per unit of risk. Moleculin Biotech is currently generating about -0.15 per unit of risk. If you would invest 31.00 in Tonix Pharmaceuticals Holding on November 3, 2024 and sell it today you would earn a total of 11.90 from holding Tonix Pharmaceuticals Holding or generate 38.39% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Tonix Pharmaceuticals Holding vs. Moleculin Biotech
Performance |
| Timeline |
| Tonix Pharmaceuticals |
| Moleculin Biotech |
Tonix Pharmaceuticals and Moleculin Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tonix Pharmaceuticals and Moleculin Biotech
The main advantage of trading using opposite Tonix Pharmaceuticals and Moleculin Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tonix Pharmaceuticals position performs unexpectedly, Moleculin Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Moleculin Biotech will offset losses from the drop in Moleculin Biotech's long position.| Tonix Pharmaceuticals vs. Sonnet Biotherapeutics Holdings | Tonix Pharmaceuticals vs. Palisade Bio | Tonix Pharmaceuticals vs. Ibio Inc | Tonix Pharmaceuticals vs. Jaguar Animal Health |
| Moleculin Biotech vs. Pulmatrix | Moleculin Biotech vs. Cyclacel Pharmaceuticals | Moleculin Biotech vs. Akari Therapeutics PLC | Moleculin Biotech vs. Bio Path Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |